Journal of Cardiothoracic and Vascular Anesthesia
Volume 22, Issue 6 , Pages 814-822 , December 2008

Cardiopulmonary Bypass Duration Is an Independent Predictor of Morbidity and Mortality After Cardiac Surgery

  • Stefano Salis, MD

      Affiliations

    • Anesthesia and Intensive Care Unit, Centro Cardiologico Monzino IRCCS, Milan, Italy
    • Corresponding Author InformationAddress reprint requests to Stefano Salis, MD, Anesthesia and Intensive Care Unit, Centro Cardiologico Monzino IRCCS, Via Parea 4, 20138 Milano, Italy
    • ,
  • Valeria V. Mazzanti, MD

      Affiliations

    • Anesthesia and Intensive Care Unit, Centro Cardiologico Monzino IRCCS, Milan, Italy
    • ,
  • Guido Merli, MD

      Affiliations

    • Anesthesia and Intensive Care Unit, Centro Cardiologico Monzino IRCCS, Milan, Italy
    • ,
  • Luca Salvi, MD

      Affiliations

    • Anesthesia and Intensive Care Unit, Centro Cardiologico Monzino IRCCS, Milan, Italy
    • ,
  • Calogero C. Tedesco

      Affiliations

    • Unit of Biostatistics, Centro Cardiologico Monzino IRCCS, Milan, Italy
    • ,
  • Fabrizio Veglia, PhD

      Affiliations

    • Unit of Biostatistics, Centro Cardiologico Monzino IRCCS, Milan, Italy
    • ,
  • Erminio Sisillo, MD

      Affiliations

    • Anesthesia and Intensive Care Unit, Centro Cardiologico Monzino IRCCS, Milan, Italy

References 

  1. Murphy GJ, Angelini GD. Side effects of cardiopulmonary bypass: What is the reality?. J Card Surg. 2004;19:481–488
  2. Cremer J, Martin M, Redl H, et al. Systemic inflammatory response syndrome after cardiac operations. Ann Thorac Surg. 1996;61:1714–1720
  3. Kaza AK, Cope JT, Fiser SM, et al. Elimination of fat microemboli during cardiopulmonary bypass. Ann Thorac Surg. 2003;75:555–559
  4. Jewell AE, Akowuah EF, Suvarna SK, et al. A prospective randomised comparison of cardiotomy suction and cell saver for recycling shed blood during cardiac surgery. Eur J Cardiothorac Surg. 2003;23:633–636
  5. Grigore AM, Grocott HP, Mathew JP, et al. The rewarming rate and increased peak temperature alter neurocognitive outcome after cardiac surgery. Anesth Analg. 2002;94:4–10
  6. Djaiani G, Fedorko L, Borger M, et al. Mild-to-moderate atheromatous disease of the thoracic aorta and new ischemic brain lesions after conventional coronary artery bypass graft surgery. Stroke. 2004;35:e356–e358
  7. Furnary AP, Wu Y, Bookin SO. Effect of hyperglycemia and continuous intravenous insulin infusions on outcomes of cardiac surgical procedures: The Portland Diabetic Project. Endocr Pract. 2004;10(suppl 2):21–33
  8. DeFoe GR, Ross CS, Olmstead EM, et al. Lowest hematocrit on bypass and adverse outcomes associated with coronary artery bypass grafting. Ann Thorac Surg. 2001;71:769–776
  9. Hazama S, Eishi K, Yamachika S, et al. Inflammatory response after coronary revascularization: Off-pump versus on-pump (heparin-coated circuits and poly2methoxyethylacrylate-coated circuits). Ann Thorac Cardiovasc Surg. 2004;10:90–96
  10. Ascione R, Lloyd CT, Underwood MJ, et al. Inflammatory response after coronary revascularization with or without cardiopulmonary bypass. Ann Thorac Surg. 2000;69:1198–1204
  11. Holcomb HB, Stammers AH, Gao C, et al. Perfusion treatment algorithm: Methods of improving the quality of perfusion. J Extra Corpor Technol. 2003;35:290–296
  12. Butler J, Rocker GM, Westaby S. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg. 1993;55:552–559
  13. Day JR, Taylor KM. The systemic inflammatory response syndrome and cardiopulmonary bypass. Int J Surg. 2005;3:129–140
  14. Ohata T, Mitsuno M, Yamamura M, et al. Beneficial effects of mini-cardiopulmonary bypass on hemostasis in coronary artery bypass grafting: analysis of inflammatory response and hemodilution. ASAIO J. 2008;54:207–209
  15. Hunt BJ, Parratt RN, Segal HC, et al. Activation of coagulation and fibrinolysis during cardiothoracic operations. Ann Thorac Surg. 1998;65:712–718
  16. Moat NE, Shore DF, Evans TW. Organ dysfunction and cardiopulmonary bypass: The role of complement and complement regulatory proteins. Eur J Cardiothorac Surg. 1993;7:563–573
  17. Butler J, Parker D, Pillai R, et al. Effect of cardiopulmonary bypass on systemic release of neutrophil elastase and tumor necrosis factor. J Thorac Cardiovasc Surg. 1993;105:25–30
  18. Zimmermann AK, Simon P, Seeburger J, et al. Cytokine gene expression in monocytes of patients undergoing cardiopulmonary bypass surgery evaluated by real-time PCR. J Cell Mol Med. 2003;7:146–156
  19. Weerasinghe A, Taylor KM. The platelet in cardiopulmonary bypass. Ann Thorac Surg. 1998;66:2145–2252
  20. Nakasuji M, Matsushita M, Asada A. Risk factors for prolonged ICU stay in patients following coronary artery bypass grafting with a long duration of cardiopulmonary bypass. J Anesth. 2005;19:118–123
  21. Palanzo DA. Perfusion safety: Defining the problem. Perfusion. 2005;20:195–203
  22. Kirklin JW. Open heart surgery at the Mayo Clinic. Mayo Clin Proc. 1980;55:339–341
  23. Taylor KM. SIRS—The systemic inflammatory response syndrome after cardiac operations. Ann Thorac Surg. 1996;61:1607–1608
  24. Whitten CW, Hill GE, Ivy R, et al. Does the duration of cardiopulmonary bypass or aortic cross-clamp, in the absence of blood and/or blood product administration, influence the IL-6 response to cardiac surgery?. Anesth Analg. 1998;86:28–33
  25. Khabar KS, elBarbary MA, Khouqeer F, et al. Circulating endotoxin and cytokines after cardiopulmonary bypass: Differential correlation with duration of bypass and systemic inflammatory response/multiple organ dysfunction syndromes. Clin Immunol Immunopathol. 1997;85:97–103
  26. Bucerius J, Gummert JF, Borger MA, et al. Stroke after cardiac surgery: A risk factor analysis of 16184 consecutive adult patients. Ann Thorac Surg. 2003;75:472–478
  27. Hogue CW, Murphy SF, Schechtman KB, et al. Risk factors for early or delayed stroke after cardiac surgery. Circulation. 1999;100:642–647
  28. Schuller AM, Windolf J, Blaheta R, et al. Degradation of microvascular brain endothelial cell beta-catenin after co-culture with activated neutrophils from patients undergoing cardiac surgery with prolonged cardiopulmonary bypass. Biochem Biophys Res Commun. 2005;329:616–623
  29. Puskas F, Grocott HP, White WD, et al. Intraoperative hyperglycemia and cognitive decline after CABG. Ann Thorac Surg. 2007;84:1467–1473
  30. D'Ancona G, Baillot R, Poirier B, et al. Determinants of gastrointestinal complications in cardiac surgery. Tex Heart Inst J. 2003;30:280–285
  31. Ohri SK, Bjarnason I, Pathi V, et al. Cardiopulmonary bypass impairs small intestinal transport and increases gut permeability. Ann Thorac Surg. 1993;55:1080–1086
  32. Kumle B, Boldt J, Suttner SW, et al. Influence of prolonged cardiopulmonary bypass times on splanchnic perfusion and markers of splanchnic organ function. Ann Thorac Surg. 2003;75:1558–1564
  33. Andersson B, Nilsson J, Brandt J, et al. Gastrointestinal complications after cardiac surgery. Br J Surg. 2005;92:326–333
  34. Perugini RA, Orr RK, Porter D, et al. Gastrointestinal complications following cardiac surgery (An analysis of 1477 cardiac surgery patients). Arch Surg. 1997;132:352–357
  35. Christenson JT, Schmuziger M, Maurice J, et al. Gastrointestinal complications after coronary artery bypass grafting. J Thorac Cardiovasc Surg. 1994;108:899–906
  36. Khuri SF, Wolfe JA, Josa M, et al. Hematologic changes during and after cardiopulmonary bypass and their relationship to the bleeding time and nonsurgical blood loss. J Thorac Cardiovasc Surg. 1992;104:94–107
  37. Parr KG, Patel MA, Dekker R, et al. Multivariate predictors of blood product use in cardiac surgery. J Cardiothorac Vasc Anesth. 2003;17:176–181
  38. Despotis GJ, Filos KS, Zoys TN, et al. Factors associated with excessive postoperative blood loss and hemostatic transfusion requirements: A multivariate analysis in cardiac surgical patients. Anesth Analg. 1996;82:13–21
  39. Zilla P, Fasol R, Groscurth P, et al. Blood platelets in cardiopulmonary bypass operations (Recovery occurs after initial stimulation, rather than continual activation). J Thorac Cardiovasc Surg. 1989;97:379–388
  40. Wahba A, Rothe G, Lodes H, et al. Effects of extracorporeal circulation and heparin on the phenotype of platelet surface antigens following heart surgery. Thromb Res. 2000;97:379–386
  41. Slaughter TF, LeBleu TH, Douglas JM, et al. Characterization of prothrombin activation during cardiac surgery by hemostatic molecular markers. Anesthesiology. 1994;80:520–526
  42. Blauhut B, Harringer W, Bettelheim P, et al. Comparison of the effects of aprotinin and tranexamic acid on blood loss and related variables after cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1994;108:1083–1091
  43. Naughton C, Reilly N, Powroznyk A, et al. Factors determining the duration of tracheal intubation in cardiac surgery: A single-centre sequential patient audit. Eur J Anaesthesiol. 2003;20:225–233
  44. Canver CC, Chanda J. Intraoperative and postoperative risk factors for respiratory failure after coronary bypass. Ann Thorac Surg. 2003;75:853–857
  45. Sinclair DG, Haslam PL, Quinlan GJ, et al. The effect of cardiopulmonary bypass on intestinal and pulmonary endothelial permeability. Chest. 1995;108:718–724
  46. Görlach G, Sroka J, Heidt M, et al. Intracellular adhesion molecule-1 in patients developing pulmonary insufficiency after cardiopulmonary bypass. Thorac Cardiovasc Surg. 2003;51:138–141
  47. Tönz M, Mihaljevic T, von Segesser LK, et al. Acute lung injury during cardiopulmonary bypass (Are the neutrophils responsible?). Chest. 1995;108:1551–1556
  48. Milot J, Perron J, Lacasse Y, et al. Incidence and predictors of ARDS after cardiac surgery. Chest. 2001;119:884–888
  49. Dimopoulou I, Daganou M, Dafni U, et al. Phrenic nerve dysfunction after cardiac operations: Electrophysiologic evaluation of risk factors. Chest. 1998;113:8–14
  50. Mangano CM, Diamondstone LS, Ramsay JG, et al. Renal dysfunction after myocardial revascularization: Risk factors, adverse outcomes, and hospital resource utilization. Ann Intern Med. 1998;128:194–203
  51. Andersson LG, Bratteby LE, Ekroth R, et al. Renal function during cardiopulmonary bypass: Influence of pump flow and systemic blood pressure. Eur J Cardiothorac Surg. 1994;8:597–602

PII: S1053-0770(08)00236-X

doi: 10.1053/j.jvca.2008.08.004

Journal of Cardiothoracic and Vascular Anesthesia
Volume 22, Issue 6 , Pages 814-822 , December 2008

Article Tools

* Image Usage & Resolution